FDA clears brain scan to diagnose ADHD in children

Published



WASHINGTON (AP) — The Food and Drug Administration has approved the first medical scan that can help diagnose attention deficit hyperactivity disorder in children by measuring brain waves.

The agency said Monday it cleared the NEBA system to help confirm ADHD for people ages 6 to 17. Doctors can use the device to confirm an ADHD diagnosis or to determine if more testing is necessary.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.